| Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers (NCT04886531) | Ruth O'Regan | 2022-07-21 |
| Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study) (NCT06525675) | MedSIR | 2022-07-18 |
| D4 Choline Breast PET/CT (NCT04276272) | Imperial College London | 2022-02-24 |
| Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study) (NCT04738292) | University of Wisconsin, Madison | 2021-10-05 |
| Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI) (NCT04568616) | Dartmouth-Hitchcock Medical Center | 2021-08-13 |
| Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer (NCT05305924) | The Methodist Hospital Research Institute | 2021-02-25 |
| Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer (NCT04504331) | Jennifer Lee Caswell-Jin | 2020-10-13 |
| A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002) (NCT04504916) | VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2020-10-07 |
| To Identify Primary Resistance to CDK4/6 Inhibitors in Breast Cancer (NCT04660435) | Fondazione Sandro Pitigliani | 2020-09-01 |
| A Study of Neoadjuvant SHR6390 in Combination With Anastrozole, Pyrotinib, and Trastuzumab in Patients With ER+/HER2+ Breast Cancer. (NCT04236310) | Ruijin Hospital | 2020-01-15 |
| Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy (NCT02345772) | Western Regional Medical Center | 2014-07-01 |
| AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer (NCT01361945) | Texas Tech University Health Sciences Center, El Paso | 2011-07-01 |
| An Observational Study to Assess Response to Tamoxifen in Breast Cancer Patients (NCT00965939) | Vlaamse Vereniging voor Obstetrie en Gynaecologie | 2009-02-01 |